These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 22384544

  • 1. [Effects of xuezhikang at different doses on patients suffering from acute coronary syndrome after percutaneous coronary intervention].
    Jiang FY, Sun LP, Yang J.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1607-10. PubMed ID: 22384544
    [Abstract] [Full Text] [Related]

  • 2. [Effects of Xuezhikang on serum levels of high sensitive-C reactive protein, matrix metalloproteinase-9 and lipoprotein in patients with acute coronary syndrome].
    Huang J, Wang MH, Peng XP, Wei C, Lu J.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Mar; 26(3):221-3. PubMed ID: 16613266
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of Xinmaitong capsule on serum matrix metalloproteinases-9, high sensitive C-reactive protein levels in patients with acute coronary syndrome].
    Meng J, Qin J, Ma Y, Sun HM, Luo CF, Qiu RX.
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):850-2. PubMed ID: 17639992
    [Abstract] [Full Text] [Related]

  • 7. [Intervention of xuezhikang on patients of acute coronary syndrome with different levels of blood lipids].
    Wang WH, Zhang H, Yu YL, Ge Z, Xue C, Zhang P.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Dec; 24(12):1073-6. PubMed ID: 15658647
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.
    Moriarty PM, Roth EM, Karns A, Ye P, Zhao SP, Liao Y, Capuzzi DM, Bays HE, Zhang F, Liu S, Reichman AJ, Brusco OA, Lu G, Lerman S, Duan Z, Guo S, Liu PL, Zhao J, Zhang Y, Li S.
    J Clin Lipidol; 2014 Dec; 8(6):568-575. PubMed ID: 25499939
    [Abstract] [Full Text] [Related]

  • 10. [Jinshuibao capsule combined losartan potassium intervened early renal damage of hypertension patients of yin and yang deficiency: a clinical research].
    Zhang CQ, Yin JQ, Xin Q, Wang YQ, Ge ZM.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):731-5. PubMed ID: 23980348
    [Abstract] [Full Text] [Related]

  • 11. [Effect of xuezhikang on blood lipids, serum oxidized low density lipoprotein, C-reactive protein and fibrinogen in patients with unstable angina pectoris].
    Yao QH, Cui CC, Wang JK.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):750-2. PubMed ID: 14626188
    [Abstract] [Full Text] [Related]

  • 12. [Effects of jingtian tongmai recipe on atherosclerotic plaque in rabbits].
    Zhao CX, Kasimu R, Wang XM.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):136-9. PubMed ID: 19382474
    [Abstract] [Full Text] [Related]

  • 13. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z, Dai H, Xing M, Yu Z, Lin X, Wang S, Zhang J, Hou F, Ma Y, Ren Y, Tan K, Wang Y, Ge Z.
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The effects of 40 mg atorvastatin on serum lipids, inflammatory markers and clinical events in ACS patients post PCI].
    Dong SH, Wen JM, Luo LJ, Chen KQ, Liang XJ, Li YF, Liu HD, Chen HZ, Huang ZX, Jiang X.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):353-6. PubMed ID: 16776933
    [Abstract] [Full Text] [Related]

  • 17. [Effect of xuezhlkang capsule in intervening different Chinese medical syndrome patterns of non-alcoholic fatty liver disease complicated with carotid atherosclerosis].
    Ou MY, Xu SH.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):159-63. PubMed ID: 21425565
    [Abstract] [Full Text] [Related]

  • 18. [Effects of naoxintong capsule on the inflammation and prognosis in borderline lesion coronary heart disease patients].
    Li SR, Wang TH, Zhang BJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May; 32(5):607-11. PubMed ID: 22679718
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.